|
Study Of Adults With Depression Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, trips or professional assistance with a real medical doctor. We aren't docs. Always confer with your doctor about Study Of Adults With Depression conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Study Of Adults With Depression Clinical research trials and Study Of Adults With Depression health trials happen in many of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the effectualness of new does drugs. The intention of the studies / projects is to figure out particular human healthcare questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to detect cures for all forms of circumstances, like Study Of Adults With Depression. Study Of Adults With Depression Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment options before they are available to the general public. Most times the subjects get treatment for free of charge, and occasionally they are paid for their time. Occasionally there is a cost for a Study Of Adults With Depression clinical trial. Subjects frequently get the best healthcare possible for their Study Of Adults With Depression condition. Hazards are a reality, however, and could include more or frequent mD visits, health risks (possibly life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with exacting guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Study Of Adults With Depression Study Of Adults With Depression
Study Of Adults With Depression
For Condition: Major Depressive Disorder
Status: No longer recruiting
Sponsor(s): Sponsor Name Pending ,
Synopsis: A Placebo Controlled Study Evaluating Efficacy, Safety and Tolerability of Medication in Patients with Major Depressive Disorder (MDD)
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/64 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria - Diagnosis of Major Depressive Disorder (MDD) - Duration of current depressive episode 12 weeks - 24 months - Patients can read and write at a level sufficient to provide a signed consent - If female, patients must be practicing an acceptable method of birth control Exclusion Criteria - Patients have other psychiatric disorders that would affect patient's response to treatment - Patients have not responded to two or more adequate courses of antidepressant therapy - Patients cannot be currently abusing illicit drugs or alcohol - Patients are not currently receiving psychotherapy - Patients have received electroconvulsive therapy within 6 months prior to screening - Patients are pregnant or lactating
Total Enrollment:
Location and Contact Information:
Study Site
Lafayette, Indiana, 47905
United States
Study Site
St. Charles, Missouri, 63301
United States
Study Site
San Diego, California, 92108
United States
Study Site
Boynton Beach, Florida, 33437
United States
Study Site
Temecula, California, 92591
United States
Study Site
Tampa, Florida, 33613
United States
Study Site
Beverly Hills, California, 90210
United States
Study Site
Rockville, Maryland, 20852
United States
Study Site
Marietta, Georgia, 30060
United States
Study Site
Jacksonville, Florida, 32216
United States
Study Site
Nashville, Tennessee, 37203
United States
Study Site
Libertyville, Illinois, 60048
United States
Study Site
Winston Salem, North Carolina, 27103
United States
Study Site
Washington D.C., District of Columbia, 20037
United States
Study Site
Oakbrook Terrace, Illinois, 60181
United States
Study Site
Albuquerque, New Mexico, 87108
United States
Study Site
Toledo, Ohio, 43623
United States
Study Site
Indianapolis, Indiana, 46202
United States
Study Site
San Antonio, Texas, 78229
United States
Study Site
Shreveport, Louisiana, 71101
United States
Study Site
Bellevue, Washington, 98004
United States
Study Site
Memphis, Tennessee, 38119
United States
Study Site
Cerritos, California, 90703
United States
Additional Information:
Study ID Numbers: OHB20003;
Study Start Date:
Record last reviewed: January 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00057226
Other Major Depressive Disorder Studies:
1. Study Of Depression In Adults
2. Efficacy And Safety Of Three Fixed Doses Of DVS-233 SR In Adult Outpatients With Major Depressive Disorder
3. Treatment of Patients with Major Depressive Disorder with an Investigational Compound
4. Open Label Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial
5. Treatment of Patients with Major Depressive Disorder with an Investigational Compound
Related Studies:
Other Major Depressive Disorder Clinical Trials
Other California Clinical Trials
Other San Diego Clinical Trials
Study Of Adults With Depression
|
|
|
|
|
|
|
|